000163052 001__ 163052
000163052 005__ 20240229123147.0
000163052 0247_ $$2doi$$a10.1016/j.ejso.2020.08.015
000163052 0247_ $$2pmid$$apmid:32907774
000163052 0247_ $$2ISSN$$a0748-7983
000163052 0247_ $$2ISSN$$a1532-2157
000163052 0247_ $$2altmetric$$aaltmetric:93784606
000163052 037__ $$aDKFZ-2020-01838
000163052 041__ $$aeng
000163052 082__ $$a610
000163052 1001_ $$aBundred, James$$b0
000163052 245__ $$aDo surgical margins matter after mastectomy? A systematic review.
000163052 260__ $$aBurlington, Mass.$$bHarcourt$$c2020
000163052 3367_ $$2DRIVER$$aarticle
000163052 3367_ $$2DataCite$$aOutput Types/Journal article
000163052 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1609157392_24571$$xReview Article
000163052 3367_ $$2BibTeX$$aARTICLE
000163052 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163052 3367_ $$00$$2EndNote$$aJournal Article
000163052 500__ $$a2020 Dec;46(12):2185-2194
000163052 520__ $$aNo consensus exists regarding adequacy of margins after mastectomy. To determine if pathological margin proximity is associated with local (LR) or distant recurrence after mastectomy for early invasive breast cancer or ductal carcinoma in situ.A systematic review of literature published from 1980 to 2019 and meta-analysis was conducted. Unpublished data were sought from authors (PROSPERO (CRD42019127541)). Thirty-four studies comprising 34,833 breast cancer patients were included in the quantitative synthesis. Eligible studies reported on patients undergoing curative mastectomy for cancer allowing estimation of outcomes in relation to margin status/width. The association between pathological margin status and local (LR) and distant recurrence was considered using random effects modelling. PRISMA guidelines were followed.Positive margins were associated with increased LR on multivariable analyses (HR, 2·64, (95%CI 2·01-3·46)) and LR was higher regardless of the distance of tumour from the margin defined as positive. After skin-sparing mastectomy, positive margins were associated with increased LR (HR 3·40, (95%CI 1·9-6·2)). In the 4 studies reporting distant recurrence, patients with involved margins had a higher risk (HR 1·53, (95%CI 1·03-2·25)).Failure to achieve clear margins after mastectomy may increase the risks of local and distant recurrence. Adequate margin clearance should be recommended to minimize recurrence after mastectomy in National and International Guidelines.
000163052 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000163052 588__ $$aDataset connected to CrossRef, PubMed,
000163052 7001_ $$aMichael, Sarah$$b1
000163052 7001_ $$aBowers, Sarah$$b2
000163052 7001_ $$aBarnes, Nicola$$b3
000163052 7001_ $$aJauhari, Yasmin$$b4
000163052 7001_ $$aPlant, Dafydd$$b5
000163052 7001_ $$aMaishman, Thomas$$b6
000163052 7001_ $$aCutress, Ramsey$$b7
000163052 7001_ $$0P:(DE-He78)53e1a2846c69064e27790dbf349ccaec$$aHolleczek, Bernd$$b8$$udkfz
000163052 7001_ $$aDodwell, David$$b9
000163052 7001_ $$aBundred, Nigel$$b10
000163052 773__ $$0PERI:(DE-600)2002481-2$$a10.1016/j.ejso.2020.08.015$$gp. S0748798320307071$$n12$$p2185-2194$$tEuropean journal of surgical oncology$$v46$$x0748-7983$$y2020
000163052 909CO $$ooai:inrepo02.dkfz.de:163052$$pVDB
000163052 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)53e1a2846c69064e27790dbf349ccaec$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000163052 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000163052 9141_ $$y2020
000163052 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEJSO-EUR J SURG ONC : 2018$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-06
000163052 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-06
000163052 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000163052 980__ $$ajournal
000163052 980__ $$aVDB
000163052 980__ $$aI:(DE-He78)C070-20160331
000163052 980__ $$aUNRESTRICTED